Please use this identifier to cite or link to this item: https://hdl.handle.net/10419/261893 
Year of Publication: 
2021
Citation: 
[Journal:] BRQ Business Research Quarterly [ISSN:] 2340-9436 [Volume:] 24 [Issue:] 1 [Publisher:] Sage Publishing [Place:] London [Year:] 2021 [Pages:] 91-111
Publisher: 
Sage Publishing, London
Abstract: 
We analyze the weaknesses of meta-analyses (MAs) in management research using as benchmark a scientific field where this technique shows a longer tradition: clinical research. We suggest four areas in which management research MA practices should improve: (1) availability of information and replicability of primary research, (2) correct application of statistical support, (3) execution of heterogeneity analyses, and (4) standardization of result reporting. Using a representative MA on an operations management topic, we identify qualitatively the aspects to be improved at each stage. We show the different results that could have been achieved by following standard procedures in clinical research, incorporating different "good practices" from this research field. Overall, these recommendations aim at improving the transparency and replicability of MAs, which can not only facilitate the accumulation of scientific knowledge but also intensify the dialogue between academia and practitioners.
Subjects: 
Meta-analysis
"good practices"
transparency
replicability
management
clinical research
JEL: 
C01
M11
M01
Persistent Identifier of the first edition: 
Creative Commons License: 
cc-by-nc-nd Logo
Document Type: 
Article

Files in This Item:
File
Size





Items in EconStor are protected by copyright, with all rights reserved, unless otherwise indicated.